Sanofi SA (SNY)
48.52
+0.44
(+0.92%)
USD |
NASDAQ |
Jun 28, 16:00
48.52
0.00 (0.00%)
After-Hours: 17:20
Sanofi Research and Development Expense (Annual): 7.284B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.284B |
| December 31, 2022 | 7.072B |
| December 31, 2021 | 6.735B |
| December 31, 2020 | 6.315B |
| December 31, 2019 | 6.739B |
| December 31, 2018 | 6.960B |
| December 31, 2017 | 6.197B |
| December 31, 2016 | 5.724B |
| December 31, 2015 | 5.640B |
| December 31, 2014 | 6.206B |
| December 31, 2013 | 6.116B |
| December 31, 2012 | 6.306B |
| December 31, 2011 | 6.676B |
| Date | Value |
|---|---|
| December 31, 2010 | 6.027B |
| December 31, 2009 | 6.391B |
| December 31, 2008 | 6.715B |
| December 31, 2007 | 6.220B |
| December 31, 2006 | 5.567B |
| December 31, 2005 | 5.029B |
| December 31, 2004 | 2.969B |
| December 31, 2003 | 1.487B |
| December 31, 2002 | 1.153B |
| December 31, 2001 | 923.53M |
| December 31, 2000 | 873.12M |
| December 31, 1999 | 970.13M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
6.315B
Minimum
2020
7.284B
Maximum
2023
6.829B
Average
6.739B
Median
2019
Research and Development Expense (Annual) Benchmarks
| AstraZeneca PLC | 10.94B |
| Novavax Inc | 737.50M |
| Regeneron Pharmaceuticals Inc | 4.439B |
| Fulcrum Therapeutics Inc | 71.80M |
| Moderna Inc | 4.845B |